← Leaderboards
Jay Williams Hooper
Geneva Foundation
$7,880,772
Attributed
$7,880,772
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2012–21$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,880,772 · 2
By mechanism
R01$7,880,772 · 2
Top collaborators
No co-investigators on record.
Most similar at Geneva Foundation
Same institution · by research overlap
- Osmer Marjorie$6,675,924
- Mainard Rachelle$2,601,888
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsPharmaceutical PreparationsGenesMesocricetus AuratusNeutralizing AntibodyOryctolagus CuniculusCyclic GmpDna VaccinesHantavirusJet InjectionsNational Institute Of Allergy And Infectious DiseaseNeedlesNonhuman PrimateCase Fatality RatesCategoriesAndes VirusDevicesDisease ProgressionAnimal ModelHamstersHantavirus Pulmonary SyndromeIntensive Care UnitsBasePrevent
Grant awards (10)
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease$379,859
R01 · FY2021 · AI · contact PI
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease$1,049,794
R01 · FY2020 · AI · contact PI
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease$1,079,215
R01 · FY2019 · AI · contact PI
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease$1,055,169
R01 · FY2018 · AI · contact PI
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease$1,037,264
R01 · FY2017 · AI · contact PI
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine$578,793
R01 · FY2016 · AI · contact PI
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine$712,297
R01 · FY2015 · AI · contact PI
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine$585,257
R01 · FY2014 · AI · contact PI
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine$742,164
R01 · FY2013 · AI · contact PI
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine$660,960
R01 · FY2012 · AI · contact PI